226 related articles for article (PubMed ID: 24947993)
1. Barriers to access for Canadians who use cannabis for therapeutic purposes.
Belle-Isle L; Walsh Z; Callaway R; Lucas P; Capler R; Kay R; Holtzman S
Int J Drug Policy; 2014 Jul; 25(4):691-9. PubMed ID: 24947993
[TBL] [Abstract][Full Text] [Related]
2. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.
Walsh Z; Callaway R; Belle-Isle L; Capler R; Kay R; Lucas P; Holtzman S
Int J Drug Policy; 2013 Nov; 24(6):511-6. PubMed ID: 24095000
[TBL] [Abstract][Full Text] [Related]
3. Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada.
Capler R; Walsh Z; Crosby K; Belle-Isle L; Holtzman S; Lucas P; Callaway R
Int J Drug Policy; 2017 Sep; 47():1-8. PubMed ID: 28667878
[TBL] [Abstract][Full Text] [Related]
4. Medical Marijuana programs: implications for cannabis control policy--observations from Canada.
Fischer B; Kuganesan S; Room R
Int J Drug Policy; 2015 Jan; 26(1):15-9. PubMed ID: 25287942
[TBL] [Abstract][Full Text] [Related]
5. Barriers to access to medical cannabis for Canadians living with HIV/AIDS.
Belle-Isle L; Hathaway A
AIDS Care; 2007 Apr; 19(4):500-6. PubMed ID: 17453590
[TBL] [Abstract][Full Text] [Related]
6. Mental Health and Medical Cannabis Use among Youth and Young Adults in Canada.
Wadsworth E; Leos-Toro C; Hammond D
Subst Use Misuse; 2020; 55(4):582-589. PubMed ID: 31747851
[No Abstract] [Full Text] [Related]
7. Cannabis education needs assessment among Canadian physicians-in-training.
St Pierre M; Matthews L; Walsh Z
Complement Ther Med; 2020 Mar; 49():102328. PubMed ID: 32147035
[TBL] [Abstract][Full Text] [Related]
8. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients.
Lucas P; Walsh Z
Int J Drug Policy; 2017 Apr; 42():30-35. PubMed ID: 28189912
[TBL] [Abstract][Full Text] [Related]
9. Cannabis in medicine: a national educational needs assessment among Canadian physicians.
Ziemianski D; Capler R; Tekanoff R; Lacasse A; Luconi F; Ware MA
BMC Med Educ; 2015 Mar; 15():52. PubMed ID: 25888752
[TBL] [Abstract][Full Text] [Related]
10. Growing medicine: small-scale cannabis cultivation for medical purposes in six different countries.
Hakkarainen P; Frank VA; Barratt MJ; Dahl HV; Decorte T; Karjalainen K; Lenton S; Potter G; Werse B
Int J Drug Policy; 2015 Mar; 26(3):250-6. PubMed ID: 25123694
[TBL] [Abstract][Full Text] [Related]
11. Cannabis for therapeutic purposes and public health and safety: a systematic and critical review.
Sznitman SR; Zolotov Y
Int J Drug Policy; 2015 Jan; 26(1):20-9. PubMed ID: 25304050
[TBL] [Abstract][Full Text] [Related]
12. Perceived support for medical cannabis use among approved medical cannabis users in Canada.
Leos-Toro C; Shiplo S; Hammond D
Drug Alcohol Rev; 2018 Jul; 37(5):627-636. PubMed ID: 29873132
[TBL] [Abstract][Full Text] [Related]
13. Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage.
Sznitman SR; Lewis N
Int J Drug Policy; 2015 May; 26(5):446-52. PubMed ID: 25661483
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.
Rotermann M; Pagé MM
Health Rep; 2018 Jul; 29(7):3-13. PubMed ID: 30020531
[TBL] [Abstract][Full Text] [Related]
15. Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada: A qualitative study.
Elliott J; DeJean D; Potter BK; Coyle D; Clifford T; McCoy B; Wells GA
Epilepsy Behav; 2020 Oct; 111():107120. PubMed ID: 32570201
[TBL] [Abstract][Full Text] [Related]
16. Reducing barriers associated with delivering health care services to migratory agricultural workers.
Schmalzried HD; Fallon LF
Rural Remote Health; 2012; 12():2088. PubMed ID: 22827833
[TBL] [Abstract][Full Text] [Related]
17. Accommodating the medical use of marijuana: surveying the differing legal approaches in Australia, the United States and Canada.
Bogdanoski T
J Law Med; 2010 Feb; 17(4):508-31. PubMed ID: 20329455
[TBL] [Abstract][Full Text] [Related]
18. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
[TBL] [Abstract][Full Text] [Related]
19. Establishing expertise: Canadian community-based medical cannabis dispensaries as embodied health movement organisations.
Penn RA
Int J Drug Policy; 2014 May; 25(3):372-7. PubMed ID: 24439711
[TBL] [Abstract][Full Text] [Related]
20. Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada.
Capler NR; Balneaves LG; Buxton JA; Kerr T
J Cannabis Res; 2023 Jun; 5(1):18. PubMed ID: 37291647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
